Imagine 2017 - International Innovation and Translation in Imaging Symposium

Returning to TRI for the second year, Imagine is an international conference featuring the world's leading imaging specialists sharing their latest developments in imaging, radiology and MRI technology and process. Hosted by the Translational Research Institute, Imagine 2017 will feature a full day of presentations by international researches and leaders from multinational organisations, followed two workshops that will examine specific challenges in the innovation and translational process. Please see the full program below.

Day 1 - Tuesday 5 September 2017	Day 2 - Wednesday 6 September 2017
8.30am - 4.30pm: Presentations 4.30pm - 6.00pm: Networking Cocktails	9.00am - 4.00pm: Workshops

                   

Imagine Event Program - day 1 - Tuesday 5th September 2017

 

Time	Speaker	Affiliation	Title
8.30am	Prof Carolyn Mountford	TRI CEO and Director of Research	Welcome to Imagine 2017
8.35am	Dr Robert Krieg	Siemens Healthcare	Welcome to Imagine 2017

Session 1 - Neuro-deregulation in front line defenders – diagnosis and treatment

Chair : Major General Paul McLachlan 

Time	Speaker	Affiliation	Title
8.50am	Major General Paul David McLachlan	Commander, 1st Division and Deployable Joint Force Headquarters, Australian Army	Need for better diagnosis and treatment of front line defenders
9.10am	Dr Walter Busuttil	Medical Director, Combat Stress, UK	Management of mental health disorders in British help-seeking Veterans
9.30am	Dr David Crompton	Executive Dean, Metro South Addiction and Mental Health Services	Are we closer to the Holy Grail?
9.50am	Prof Carolyn Mountford	TRI CEO and Director of Research	Neuro-chemical evaluation of PTSD and Blast Exposure
10.05am	Dr John Irvine	Chief Scientist, Data Analytics, Draper Laboratories, Boston, USA	New methods for biomarker discovery from MRS Signals
10.25 am	Morning Tea	TRI Atrium

Session 2 - Imaging Response to Immunotherapy  MRI and MRI-PET

Chair: Prof  Herb Kressel (Boston) 

Time	Speaker	Affiliation	Title
11.00am	Prof Alberto Bizzi	Carlo Besta Neurological Institute Milan, Italy	Imaging response to immunotherapy
11.30am	Prof Ken Miles	Radiologist, PAH, Institute of Nuclear Medicine, University College London	PET/MRI biomarkers in oncology: towards personalisation of immune targeted therapy for body tumours
12.00 noon	Prof Stephen Rose	Senior Principal Research Scientist, CSIRO	The role of molecular imaging in glioma research
12.15pm	Michael Kean	Royal Children's Hospital, Melbourne	MRI-PET in Paediatric Oncology: beyond the status go!
12.30	Lunch	TRI Atrium

Session 3 - Cardiac MR

Chair: Dr Richard Slaughter (Brisbane)

Time	Speaker	Affiliation	Title
1.15pm	A/Prof Brett Cowan	University of Auckland and General Manager, UniServices Management	Commercialisation and innovation in Cardiac MRI analysis
1.45pm	Prof Stuart Grieve	Chair of Radiology, Sydney Medical School	4d-flow MRI of the aorta
2.00pm	Dr Arnold Ng	Senior Cardiologist, Princess Alexandra Hospital	Metabolic heart disease
2.15pm	Interval	TRI Atrium

Session 4 MR guided radiotherapy

Chair: Dr Kirby Vosburgh (Boston)

Time	Speaker	Affiliation	Title
2.30pm	Professor Sandro V Porceddu   *A/Prof Clifton David Fuller	Director of Radiation Oncology Research, Cancer Services Princess Alexandra Hospital, Metro South Health and Associate Editor, Oral Oncology	Integration of functional imaging in the management of head and neck cancer
3.00pm	Dr Liz Kenny	Medical Director, Cancer Services Central, Royal Brisbane & Women’s Hospital	The importance of targeted local treatment and changing the evidence paradigm in cancer
3.15pm	Prof Stuart Crozier	Associate Dean, Research UQ Faculty of Engineering, Architecture and Information Technology	Development of MRI guided radiotherapy
3.30pm	Dr Robert Krieg	Siemens Healthcare	MR-guided Therapy
3.45pm	Closing Panel Discussion		Prof Carolyn Mountford Chair,  Dr Herb Kressel, Prof Alberto Bizzi , Dr Walter Busuttil, Prof David Crompton, A/Prof Clifton David, Prof Liz Kenny
4.15pm	Dr Christine Williams	Chief Scientist Queensland Government	Conference close- Innovation in Queensland
4.30pm	Conference close

*Unfortunatley A/Prof Clifton David Fuller from the University of Texas MD Anderson Cancer Centre, is unable to attend due to recent flooding in the US. 

Day 2 - Wednesday 6th September 2017

Day 2 will feature two three-hour workshop sessions.   The first, chaired by Mark Sowerby, Queensland's Chief Entrepreneur, examines how government hopes to support the translation of innovation; what investors are looking for; what innovators are hoping to achieve; and what the industry partner needs.  The second, chaired by Prof David Whiteman, QIMR asks 'Deep Learning and power calculations: Do we need both?'

Workshop 1: What can Australia and Queensland learn from Boston about Translation?  

Time	Speaker	Affiliation	Topic
9.00am	Mark Sowerby	Chief Entrepreneur, DSITI Queensland	Why is Government support of medical innovation important to bring about commercilisation?
9.20am	Dr Christine Williams	Chief Scientist, DSITI Queensland	Advance Queensland and the support of translational efforts focused on key health needs of Queenslanders.
9.40am	Mike Molinari	Investment Manager, Brandon Capital Partners	Seed and venture capital to support life science companies: what are investors looking for?
10.30am	Prof Kirby Vosburgh	Harvard Consortia for Improving Medicine with Innovation and Technology	Experiences in Boston- gaining institutional and project success.
11.00am	Elliot Smith	Co-founder MaxwellMRI	Industry perspective from a new start-up MaxwellMRI.
11.30am	Round table discussion	Session speakers
12.00noon	Lunch	Atrium

Workshop 2: Deep Learning and Power Calculations - Do we need both?

Chair: Prof David Whiteman

Time	Speaker	Affiliation	Topic
1.00pm	Prof David Whiteman	Medical Epidemiologist, QIMR Berghofer	Introduces session
1.10pm	Prof Herb Kressel MD	Harvard Medical School	Reproducibility of results a concern to hospitals, the journals and to industry
1.40pm	Dr John Irvine	Draper Laboratory, Boston	Do results generalise in clinical practice?
2.30-2.45pm	Interval
2.45pm	Dr Gunter Hartel	QIMR Berghofer	Are we wasting money on RCTs because power calculations are irrelevant in a multivariate situation, which all health issues are?
3.15pm	Round Table Discussion		Session Speakers

'Deep Learning and Power Calculations' supported by: QIMR Berghofer 

 

Imagine 2017 Proudly supported by